Results 51 to 60 of about 4,684,794 (400)

Real-practice thromboprophylaxis in atrial fibrillation [PDF]

, 2017
This retrospective observational study was based on databases of the Local Health Authority of Treviso, Italy. It evaluated the prevalence and the effectiveness of oral anticoagulation treatment (OAT) for the management of nonvalvular atrial fibrillation
Bettiol, Alessandra, Bolcato, Jenny, Chinellato, Alessandro, Deambrosis, Paola, Franchin, Giulia, Giusti, Pietro, Pellizzari, Michele, Pirolo, Roberta, Themistoclakis, Sakis   +8 more
core   +2 more sources

PATTERN OF ANTICOAGULANT THERAPY IN CARDIOEMBOLIC STROKE

Malang Neurology Journal, 2023
Background: Cardioembolic stroke is a category of ischemic stroke that manifests more severe, is prone to recurrence, and is related to a higher mortality rate than the other categories of ischemic stroke.
Reihan Achmad Reza, Lisda Amalia, Nushrotul Lailiyya Dahlan, Cep Juli, Hanna Goenawan   +4 more
doaj   +1 more source

Mechanical thrombextraction in patient with acute ischemic stroke on background of oral anticoagulant therapy [PDF]

Кардіохірургія та інтервенційна кардіологія, 2021
Thrombolytic therapy, which is a priority treatment strategy in patients with acute ischemic stroke in the first 3-4.5 hours after start of the disease, has significant limitations in case of background anticoagulant therapy. Mechanic thrombextraction is
V.О. Yarosh, V.V. Babenko, O.E. Svyrydiuk, O.J. Zharinov, O.A. Yepanchintseva, B.M. Todurov   +5 more
doaj   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M, Athanasoulis CA, Bergqvist D, Bergqvist D, Buller HR, Clagett PG, Da Silva MS, Decousus H, ENOXACAN Study Group, Falanga A, Geerts WH, Gitter MJ, Goldenberg N, Gomes MPV, Green D, Haas S, Heit JA, Hettiarachchi RJK, Hull R, Hutten BA, International Multicentre Trial, Johnson MJ, Kakkar VV, Karthaus M, Koopman MMW, Levine MN, Mousa S A, Mousa SA, Prandoni P, Rasmussen MS, Rickles FR, Sallah S, Samama M, Siragusa B, The Columbus Investigators, White RH, Zacharski LR   +36 more
core   +1 more source

Trend of anticoagulant therapy in elderly patients with atrial fibrillation considering risks of cerebral infarction and bleeding

Scientific Reports, 2023
The introduction of direct oral anticoagulants (DOACs) has greatly changed the use of anticoagulant therapy in patients with non-valvular atrial fibrillation (Af).
Noriko Tsuji, Yoshimitsu Takahashi, Michi Sakai, Shosuke Ohtera, Junji Kaneyama, Kosai Cho, Genta Kato, Shigeru Ohtsuru, Takeo Nakayama   +8 more
doaj   +1 more source

Bleeding in a COVID-19 Patient; Rectus Hematoma

Northwestern Medical Journal, 2021
Anticoagulant therapy is part of the treatment of hospitalized COVID-19 patients. Low molecular weight heparin or oral anticoagulant drugs are used in its treatment. However this approach may increase the risks of bleeding.
Kader Zeybek Aydoğan, Selman Alkan, Elif Ayşe Uçar   +2 more
doaj   +1 more source

Treatment of bleeding complications in patients on anticoagulant therapy.

Blood, 2019
Anticoagulant therapy is often refrained from out of fear of hemorrhagic complications. The most frequent type of major bleeding is gastrointestinal, but intracranial hemorrhage has the worst prognosis.
Siavash Piran, S. Schulman
semanticscholar   +1 more source

Perioperative management of anticoagulant therapy

Innovative Surgical Sciences, 2019
About 10% of patients taking a chronic, oral anticoagulant therapy require an invasive procedure that can be associated with an increased risk for peri-interventional or perioperative bleeding.
Wagner Johanna, Lock Johan F., Kastner Carolin, Klein Ingo, Krajinovic Katica, Löb Stefan, Germer Christoph-Thomas, Wiegering Armin   +7 more
doaj   +1 more source

The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice : systematic review and economic evaluation [PDF]

, 2015
Funding The National Institute for Health Research Health Technology Assessment programme.Peer reviewedPublisher ...
, , , , , , , , , , , , , , , , , , , , Ahmad, Ansell, Ascione, Azarnoush, Bauman, Bauman, Bauman, Bayer, Bereznicki, Bloomfield, Braun, Briggs, Bronnum-Hansen, Brown, Cayley, Christensen, Christensen, Christensen, Christensen, Christensen, Christensen, Connock, Connolly, Cromheecke, Curtis, Dauphin, DeWilde, Dorman, Drummond, Dunning, Edwards, Eitz, Fitzmaurice, Fitzmaurice, Fitzmaurice, Friberg, Friberg, Fuster, Gadisseur, Gadisseur, Gailly, Gallagher, Garcia-Alamino, Gardiner, Gardiner, Go, Hallan, Havrda, Hemkens, Heneghan, Heneghan, Hentrich, Higgins, Hobbs, Horstkotte, Horstkotte, Horstkotte, Hylek, Jackson, Jones, Jones, Jowett, Kannel, Khan, Kind, Kitchen, Koertke, Koertke, Koertke, Kvidal, Körtke, Körtke, Lafata, Lee, Marini, Matchar, Matchar, Matchar, McCahon, Menéndez-Jándula, Moher, Moon, Muller, Murray, Paioni, Pollack, Rasmussen, Regier, Robinson, Rose, Ruel, Ryan, Ryan, Ryan, Saka, Sawicki, Sawicki, Schmidt, Sidhu, Siebenhofer, Siebenhofer, Slot, Sobieraj-Teague, Sola-Morales, Soliman Hamad, Spackman, Sudlow, Sullivan, Sundberg, Sunderji, Sunderji, Taborski, Tamayo, Vahanian, van, Verret, Visnansky, Voller, Völler, Wallentin, Wallentin, Wang, Wardlaw, Wells, Williams, You   +145 more
core   +1 more source

A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study)

PLoS Medicine, 2018
Background Atrial fibrillation (AF) is associated with substantial morbidity, in particular stroke. Despite good evidence for the reduction of stroke risk with anticoagulant therapy, there remains significant undertreatment.
L. Karlsson, S. Nilsson, M. Bång, L. Nilsson, E. Charitakis, M. Janzon   +5 more
semanticscholar   +1 more source